Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Piccini

Showing results (521-530 of 538) with videos related to

Pageof 54
Sort By:
Journal of the American College of Cardiology|August 4, 2018
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID TrialWojciech Zareba, James P Daubert, Christopher A Beck, et al.
JACC. Heart Failure|May 3, 2019
Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF TrialJonathan P Piccini, William T Abraham, Christopher Dufton, et al.
JAMA Cardiology|March 26, 2025
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical TrialJohn H Alexander, Elizabeth J Lydon, Jonathan P Piccini, et al.
The New England Journal of Medicine|September 3, 2024
Asundexian versus Apixaban in Patients with Atrial FibrillationJonathan P Piccini, Manesh R Patel, Jan Steffel, et al.
Circulation|January 25, 2021
Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual WorkshopEmelia J Benjamin, Alan S Go, Patrice Desvigne-Nickens, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
The New England Journal of Medicine|April 27, 2026
Pulsed Field Ablation as Initial Therapy for Persistent Atrial FibrillationOussama M Wazni, K R Julian Chun, Devi G Nair, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
Circulation|November 30, 2023
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesJosé A Joglar, Mina K Chung, Anastasia L Armbruster, et al.
Journal of the American College of Cardiology|December 3, 2023
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, José A Joglar, Mina K Chung, et al.
Pageof 54

Showing results (521-530 of 538) with videos related to

Sort By:
Pageof 54
Journal of the American College of Cardiology|August 4, 2018
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID TrialWojciech Zareba, James P Daubert, Christopher A Beck, et al.
JACC. Heart Failure|May 3, 2019
Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF TrialJonathan P Piccini, William T Abraham, Christopher Dufton, et al.
JAMA Cardiology|March 26, 2025
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical TrialJohn H Alexander, Elizabeth J Lydon, Jonathan P Piccini, et al.
The New England Journal of Medicine|September 3, 2024
Asundexian versus Apixaban in Patients with Atrial FibrillationJonathan P Piccini, Manesh R Patel, Jan Steffel, et al.
Circulation|January 25, 2021
Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual WorkshopEmelia J Benjamin, Alan S Go, Patrice Desvigne-Nickens, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
The New England Journal of Medicine|April 27, 2026
Pulsed Field Ablation as Initial Therapy for Persistent Atrial FibrillationOussama M Wazni, K R Julian Chun, Devi G Nair, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
Circulation|November 30, 2023
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesJosé A Joglar, Mina K Chung, Anastasia L Armbruster, et al.
Journal of the American College of Cardiology|December 3, 2023
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, José A Joglar, Mina K Chung, et al.
Pageof 54